{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:01:33Z","timestamp":1791550893739,"version":"4.3.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The US Preventive Services Task Force has not recommended osteoporosis screening in men. Department of Veterans Affairs clinicians reviewed the literature on male osteoporosis screening and treatment. They concluded that targeted screening identifies men at risk and osteoporosis drugs reduce fracture risk similarly in men and women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose\/Introduction<\/jats:title>\n            <jats:p>The US Preventive Services Task Force (USPSTF) has found insufficient evidence for recommending for or against osteoporosis screening in men. Department of Veterans Affairs osteoporosis experts reviewed the literature on osteoporosis screening and treatment in men.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Although not done systematically, the literature was reviewed by a panel of 20 Department of Veterans Affairs clinicians with extensive experience with osteoporosis in men. Virtual meetings and multiple email communications resulted in a consensus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Screening, particularly targeted screening in men, has been found to identify men at risk for fracture. Prior studies have shown osteoporosis drugs have similar effects in men and women. A recent large observational trial demonstrated that hip fracture risk is similarly reduced for both sexes by current medications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The consensus of the panel was that targeted screening of men for osteoporosis would lead to greater use of osteoporosis medication, lowering fracture risk.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00198-024-07337-5","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T16:57:44Z","timestamp":1734109064000},"page":"163-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rationale for osteoporosis screening in men"],"prefix":"10.1007","volume":"36","author":[{"given":"Radhika R.","family":"Narla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2019-0417","authenticated-orcid":false,"given":"Robert A.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"11","key":"7337_CR1","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","volume":"29","author":"NC Wright","year":"2014","unstructured":"Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29(11):2520\u20132526","journal-title":"J Bone Miner Res"},{"issue":"5\u20136","key":"7337_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/08982643221132450","volume":"35","author":"BL Moreland","year":"2023","unstructured":"Moreland BL, Legha JK, Thomas KE, Burns ER (2023) Hip fracture-related emergency room visits, hospitalizations and deaths by mechanism of injury among adults aged 65 and older, United States 2019. J Aging Health 35(5\u20136):345\u2013355","journal-title":"J Aging Health"},{"issue":"4","key":"7337_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/jim-2018-000907","volume":"67","author":"RR Narla","year":"2019","unstructured":"Narla RR, Hirano LA, Lo SHY, Anawalt BD, Phelan EA, Matsumoto AM (2019) Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures. J Investig Med 67(4):743\u2013749","journal-title":"J Investig Med"},{"key":"7337_CR4","doi-asserted-by":"crossref","unstructured":"Khan AN, Jones RB, Khan N, Yang YX, Adler RA (2024) Trends in hip fracture rates in male veterans. Osteoporos Int 35(12):2137\u20132144","DOI":"10.1007\/s00198-024-07236-9"},{"issue":"7","key":"7337_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00198-020-05334-y","volume":"31","author":"EM Lewiecki","year":"2020","unstructured":"Lewiecki EM, Chastek B, Sundquist K, Williams SA, Weiss RJ, Wang Y, Fitzpatrick LA, Curtis JR (2020) Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017. Osteoporos Int 31(7):1299\u20131304","journal-title":"Osteoporos Int"},{"issue":"12","key":"7337_CR6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.mayocp.2018.06.024","volume":"93","author":"CS Col\u00f3n-Emeric","year":"2018","unstructured":"Col\u00f3n-Emeric CS, Pieper CF, Van Houtven CH, Grubber JM, Lyles KW, Lafleur J, Adler RA (2018) Limited osteoporosis screening effectiveness due to low treatment rates in a national sample of older men. Mayo Clin Proc 93(12):1749\u20131759","journal-title":"Mayo Clin Proc"},{"key":"7337_CR7","first-page":"31","volume":"29","author":"RA Adler","year":"2012","unstructured":"Adler RA, Semla T, Cunningham F, Pogach L (2012) The VHA male osteoporosis program: a national model for bone health. Fed Pract 29:31\u201337","journal-title":"Fed Pract"},{"key":"7337_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(17)32640-5","volume":"391","author":"L Shepsone","year":"2018","unstructured":"Shepsone L, Lenaghan E, Cooper C, Clarke S, Fon-Soe-Khloe R, Fordham R, Gittoes N, Harvey I, Harvey N, Heawood A, Holland R, Howe A, Kanis J, Marshall T, O\u2019Neill T, Peters T, Redmond N, Torgeson D, Turner D (2018) McCloskey E, for the SCOOP Study Team. Screening in the community to reduce fractures in older women (SCOOP): a randomized controlled trial. Lancet 391:741\u2013747","journal-title":"Lancet"},{"issue":"5","key":"7337_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bluic","year":"2009","unstructured":"Bluic D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513\u2013517","journal-title":"JAMA"},{"key":"7337_CR10","doi-asserted-by":"publisher","unstructured":"Keaveny TM, Adams AL, Orwoll ES, Khosla S, Siris ES, McClung MR, Bouxsein ML, Fatemi S, Lee DC, Kopperdahl DL (2024) Osteoporosis treatment prevents hip fracture similarly in both sexes: the FOCUS observational study. J Bone Mineral Res , zjae090, https:\/\/doi.org\/10.1093\/jbmr\/zjae090.","DOI":"10.1093\/jbmr\/zjae090"},{"issue":"10","key":"7337_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/jbmr\/zjae129","volume":"39","author":"RD Blank","year":"2024","unstructured":"Blank RD (2024) Trial emulation to improve fracture prevention treatment in men: editorial on ASBMR-24030174. J Bone Miner Res 39(10):1375\u20131376","journal-title":"J Bone Miner Res"},{"key":"7337_CR12","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","volume":"367","author":"S Boonen","year":"2012","unstructured":"Boonen S, Reginster JY, Kaufman JM, Lippuner K, Sanchetta J, Langdahl B, Rizzoli R, Lipschitz S, Dimai HP, Witvrouw R, Eriksen E, Brixen K, Russo L, Claessens F, Papanastasiou P, Antunez O, Su G, Bucci-Rechtweg C, Hruska J, Incera E, Vanderschueren D, Orwoll E (2012) N Engl J Med 367:1714\u20131723","journal-title":"N Engl J Med"},{"key":"7337_CR13","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s40520-023-02478-9","volume":"35","author":"C Beaudart","year":"2023","unstructured":"Beaudart C, DemonceauC Sabico S, Veronese N, Cooper C, Harvey N, Fuggle N, Bruyere O, Rizzoli R, Reginster J-Y (2023) Efficacy of osteoporosis pharmacologic treatments in men: a systematic review and meta-analysis. Aging Clin Exper Res 35:1789\u20131806","journal-title":"Aging Clin Exper Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07337-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T09:56:51Z","timestamp":1739440611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07337-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7337"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07337-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}